Australia markets closed

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.97-0.30 (-2.66%)
At close: 04:00PM EDT
10.97 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
187,118
187,118
141,838
94,419
57,365
Cost of revenue
35,181
35,181
25,532
16,888
12,470
Gross profit
151,937
151,937
116,306
77,531
44,895
Operating expenses
Research development
15,440
15,440
13,584
10,204
5,847
Selling general and administrative
187,925
187,925
137,566
83,837
38,193
Total operating expenses
203,365
203,365
151,150
94,041
44,040
Operating income or loss
-51,428
-51,428
-34,844
-16,510
855
Interest expense
5,167
5,167
4,398
4,060
4,523
Total other income/expenses net
342
342
-4,886
1
-
Income before tax
-49,527
-49,527
-42,815
-20,552
-3,668
Income from continuing operations
-49,527
-49,527
-42,815
-20,552
-3,668
Net income
-49,527
-49,527
-42,815
-20,552
-3,668
Net income available to common shareholders
-49,527
-49,527
-42,815
-20,748
-4,308
Basic EPS
-0.77
-0.81
-0.77
-0.43
-0.10
Diluted EPS
-0.77
-0.81
-0.77
-0.43
-0.10
Basic average shares
55,277
60,852
55,277
48,416
43,903
Diluted average shares
55,277
60,852
55,277
48,416
43,903